Analysis of the mechanism of adrenergic actions on ventricular vulnerability.
D000605:Amino Alcohols / Q000494:pharmacology*; D000758:Anesthesia; D000818:Animals; D002339:Carotid Arteries / Q000502:physiology; D004285:Dogs; D004558:Electric Stimulation; D004594:Electrophysiology / Q000295:instrumentation; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006352:Heart Ventricles / Q000187:drug effects*; D008297:Male; D009578:Nitrobenzenes / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D009991:Oscillometry; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011984:Sensory Receptor Cells; D013233:Stellate Ganglion; D013565:Sympatholytics / Q000494:pharmacology*; D014693:Ventricular Fibrillation; D016276:Ventricular Function
D000605:Amino Alcohols; D009578:Nitrobenzenes; D013565:Sympatholytics; D010643:Phenoxybenzamine; D009638:Norepinephrine; D004837:Epinephrine